# Trade Mark Journal No.2025/032 8 August 2025

## WO0000001864581 (1,5,40)

Office of origin: United States of America

Date of International Registration:11 December 2024
Date of designation in the UK: 11 December 2024

International priority date claimed: 9 September 2024 (United States of America) (98741806)

Class 1
  RNA polymerase; Biotechnology reagents, namely, RNA polymerase and RNA polymerase formulations; Enzymes for use in the preparation and creation of DNA and RNA.
Class 5
  Therapeutic RNA, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes; Reagents for medical or veterinary use.
Class 40
  Custom manufacturing of pharmaceuticals; Custom manufacture of therapeutic drugs, including therapeutic DNA, RNA, genes and oligonucleotides; Providing custom manufacture of mRNA and long RNA for others, namely, custom synthesis and combinations of mRNA and long RNA molecules; Custom manufacture of oligonucleotides or RNAs for use in genetic research, pharmaceutical therapies, medical research and treatment of various conditions and disorders.

TriLink BioTechnologies, LLC

Representative: Lindsay J. Hulley Rutan & Tucker, LLP, 18575 Jamboree Road, 9th Floor, Irvine CA 92612, UNITED STATES OF AMERICA